The Tisch Cancer Institute Earns Second Consecutive Designation from... Posted By: Anonymous | Posted On: Sep 24,2020 23:00 pm | View: 49
The Tisch Cancer Institute at Mount Sinai (TCI) has been awarded $13 million as part of the renewal of its National Cancer Institute Cancer Center Designation, a prestigious distinction that is based... read more ...
CarraShield Labs Issued Ground-breaking Patent for Anti-viral Gel... Posted By: Anonymous | Posted On: Sep 23,2020 23:00 pm | View: 30
CarraShield Labs, Inc. announced today that Chief Scientist Dr. Mario Tremblay has been issued a U.S. patent for a radically new gel technology that has been shown to block HPV infections in clinical... read more ...
Society for Immunotherapy of Cancer to Host Intensive Cancer... Posted By: Anonymous | Posted On: Sep 22,2020 23:00 pm | View: 22
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the third annual Cancer Immunotherapy Winter School, a comprehensive educational program, being held virtually on Feb. 22–24,... read more ...
Accelerating Drug Development Timelines – Evolution in Trial Design... Posted By: Anonymous | Posted On: Sep 21,2020 23:00 pm | View: 35
In this free webinar, the featured speakers will discuss Complex Innovative Design (CID) for clinical trial program development including master protocols, phase-less trial designs and other... read more ...
Cardiac Safety in Oncology Drug Development – The Role of ECG and... Posted By: Anonymous | Posted On: Sep 18,2020 23:00 pm | View: 64
In this free webinar, the featured speaker will introduce cardio-oncology in oncology drug development and discuss regulatory consideration and trial design approaches related to ECG endpoints such as... read more ...
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.
